Drug Promotion: M&A, Old Social Media Posts Can Increase Risk Of US FDA Enforcement

Elephant in the room
Like an elephant, the FDA never forgets what it tells sponsors about their promotional campaigns. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from FDLI